Search

Author/Creator Roesgen, V.

1. Expression of Indoleamine 2, 3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial. (March 2019)

Authors:
Kruger, S.; Ormanns, S.; Roesgen, V.; Legenstein, M.; Haas, M.; Westphalen, C.B.; Duewell, P.; Schnurr, M.; Kirchner, T.; von Bergwelt-Baildon, M.; Heinemann, V.; Boeck, S.
Journal:
European journal of cancer
Issue:
Volume 110(2019)Supplement 1
Page Start:
S16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search